Inovio Pharmaceuticals, Inc.
Oral mucosal electroporation device and use thereof
Last updated:
Abstract:
The present invention relates to electroporation (EP) devices that are able to generate an electroporation causing electrical field at the mucosal layer, and preferably in a tolerable manner. Further, it includes the generation of a protective immune response, cellular and/or humoral, using the oral EP device along with a genetic construct that encodes an immunogenic sequence.
Status:
Grant
Type:
Utility
Filling date:
12 Nov 2018
Issue date:
2 Feb 2021